Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2.
Tang J, Wang C, Feng Y, Yang W, Song H, Chen Z, Yu H, Pan X, Zhou X, Wang H, Wu B, Wang H, Zhao H, Lin Y, Yue J, Wu Z, He X, Gao F, Khan AH, Wang J, Zhao GP, Wang Y, Wang X, Chen Z, Gao GF. · 2006
Read Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. by Tang J, Wang C, Feng Y, Yang W, Song H, Chen Z, Yu H, Pan X, Zhou X, Wang H, Wu B, Wang H, Zhao H, Lin Y, Yue J, Wu Z, He X, Gao F, Khan AH, Wang J, Zhao GP, Wang Y, Wang X, Chen Z, Gao GF. (2006) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc1434494.txt.
Introduction
A pig germ caused a severe outbreak in China in the summer of 2005. Tang and co-authors investigated cases of toxic shock, a crash marked by fever, low blood pressure, and organ failure. The germ was Streptococcus suis type 2, a microbe of pigs that rarely harms people.
The team studied sick people and pigs, and grew 45 germ strains from samples. Tests in pigs and gene checks showed the strains were strong and closely matched. Tang also linked the outbreak to a like event in 1998. Their report marks the first clear proof that this pig germ can cause toxic shock in people.
Catalog record
| CREATOR | Tang J, Wang C, Feng Y, Yang W, Song H, Chen Z, Yu H, Pan X, Zhou X, Wang H, Wu B, Wang H, Zhao H, Lin Y, Yue J, Wu Z, He X, Gao F, Khan AH, Wang J, Zhao GP, Wang Y, Wang X, Chen Z, Gao GF. |
|---|---|
| YEAR | 2006 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Streptococcal Toxic Shock Syndrome Caused by Streptococcus suis Serotype 2 By Jiaqi Tang, Changjun Wang, Youjun Feng, Weizhong Yang, Huaidong Song, Zhihai Chen, Hongjie Yu, Xiuzhen Pan, Xiaojun Zhou, Huaru Wang, Bo Wu, Haili Wang Published in: PLoS Medicine DOI: 10.1371/journal.pmed.0030151 ABSTRACT Background Streptococcus suis serotype 2 ( S. suis 2, SS2) is a major zoonotic pathogen that causes only sporadic cases of meningitis and sepsis in humans. Most if not all cases of Streptococcal toxic shock syndrome (STSS) that have been well-documented to date were associated with the non-SS2 group A streptococcus (GAS). However, a recent large-scale outbreak of SS2 in Sichuan Province, China, appeared to be caused by more invasive deep-tissue infection with STSS, characterized by acute high fever, vascular collapse, hypotension, shock, and multiple organ failure. Methods and Findings We investigated this outbreak of SS2 infections in both human and pigs, which took place from July to August, 2005, through clinical observation and laboratory experiments. Clinical and pathological characterization of the human patients revealed the hallmarks of typical STSS, which to date had only been associated with GAS infection. Retrospectively, we found that this outbreak was very similar to an earlier outbreak in Jiangsu Province, China, in 1998. We isolated and analyzed 37 bacterial strains from human specimens and eight from pig specimens of the recent outbreak, as well as three human isolates and two pig isolates from the 1998 outbreak we had kept in our laboratory. The bacterial isolates were examined using light microscopy observation, pig infection experiments, multiplex-PCR assay, as well as restriction fragment length polymorphisms (RFLP) and multiple sequence alignment analyses. Multiple lines of evidence confirmed that highly virulent strains of SS2 were the causative agents of both outbreaks. Conclusions We report, to our knowledge for the first time, two outbreaks of STSS caused by SS2, a non-GAS streptococcus. The 2005 outbreak was associated with 38 deaths out of 204 documented human cases; the 1998 outbreak with 14 deaths out of 25 reported human cases. Most of the fatal cases were characterized by STSS; some of them by meningitis or severe septicemia. The molecular mechanisms underlying these human STSS outbreaks in human beings remain unclear and an objective for further study. INTRODUCTION Streptococcus suis is responsible for a variety of diseases in pigs, including meningitis, septicemia, arthritis, pneumonia, and even acute death, causing great economic loss in the pig industry worldwide every year [ 1, 2]. So far, 35 different serotypes of S. suis have been identified based on variation in the capsular antigens [ 2]. S. suis serotype 2 ( S. suis 2 or SS2) is the most frequently isolated serotype worldwide, and it comprises pathogenic, weakly pathogenic, and nonpathogenic strains [ 1– 4]. Various bacterial components such as extracellular and cell membrane–associated proteins have been suggested as virulence-associated factors, but their precise roles in the pathogenesis or virulence of S. suis have not been established [ 3, 4]. Currently, attempts to control the diseases caused by S. suis are still hampered by the lack of sufficient knowledge of pathogenesis mechanisms. Besides causing disease in pigs, S. suis 2 can also cause serious enzootic infections in humans, which are associated with septicemia, meningitis, and endocarditis [ 5]. There have been nearly 200 cases of S. suis 2 infection in humans worldwide since the first case of meningitis was recorded in Denmark in 1968 (China CDC, http://www.chinacdc.net.cn). Streptococcal toxic shock syndrome (STSS) refers to severe human invasive infection caused by Streptococcus pyogenes (S. pyogenes), a member of the group A streptococci (GAS) [ 6– 8] (Note, the abbreviation of STSS originally referred to staphylococcal toxic shock syndrome [TSS] and was borrowed later for TSS caused by S. pyogenes). Most invasive GAS disease occurs sporadically, but recent years have seen a rise of cases reported worldwide [ 9– 11]. GAS produces many toxins responsible for the clinical manifestations seen in infected patients. Some of them, labeled streptococcal pyrogenic exotoxins, have been characterized as superantigens [ 12, 13]. More recently, M protein, a constituent of the cell wall of S. pyogenes, has been found to be an important virulent factor and implicated in the pathological mechanism of STSS [ 14, 15]. STSS caused by non-GAS streptococci, including group B streptococci, group C streptococci, and group G streptococci, has not been well documented [ 16, 17]. Here we describe two recent outbreaks of S. suis 2, a non-GAS, in China and characterize the STSS they caused in human patients. METHODS Clinical Observations Faced with an unknown human infection outbreak in June 2005, in Ziyang County, Sichuan Province, China, we formed a team to investigate the event and to provide a comprehensive characterization of the patients. As we recognized the similarity to an earlier outbreak in 1998, we also analyzed retrospective data and analyzed stored samples from that outbreak. All work on autopsy samples (including the immunohistochemistry experiments described below) was carried out with written consent from relatives and approved by the Sichuan Provincial CDC ethics committee. Isolation and Identification of the Pathogen To uncover the cause of the mysterious outbreak, blood, liver, and spleen samples were collected from the affected swine and humans. To isolate a possible bacterial pathogen, several selective media ( Protocol S1) [ 18] were utilized to propagate inoculums from these samples. Subsequently, Gram staining was performed according to the standard protocol [ 18], and the resultant slides were observed under an optical microscope. Candidate isolates were grown in Todd-Hewitt broth (THB, code CM189; Oxoid, Basingstoke, Hampshire, United Kingdom) for genomic DNA isolation, and plated on Columbia agar blood base (code CM331; Oxoid) containing 6% (vol/vol) sheep blood to differentiate their haemolytic types [ 18]. Light and Electron Microscopy of Pathological Sections To study pathological changes of the patients with S. suis 2–caused STSS, we used light microscopy for initial observations. Liver and spleen tissues from the autopsy specimen were selected to prepare sections for further transmission electron microscopy (TEM) observation ( Protocol S1). Immunohistochemistry Experiments To examine details of the pathological changes and detect specific antigens in the infected tissues, immunohistochemistry was applied to formalin-fixed paraffin-embedded liver sections ( Protocol S1). Primary antibodies (anti– S. suis 2 serum derived from the recovered pig infected by S. suis 2) and normal pig serum were used at a dilution of 1:50. The Histo-stain Plus Kit (Zymed Laboratories, South San Francisco, United States) was used for detection. Sections were briefly counterstained with haematoxylin. Pig Infection Experiments To test the pathogenicity of the bacterium agent, infection experiments were performed in pigs [ 19, 20] ( Protocol S1). The challenged piglets were monitored for clinical signs of the disease every 3 h. Bacterial pathogens were recovered from those piglets that showed marked signs of illness or had died 30 h post-infection. All experiments were conducted in a biosafety level 3 (BSL-3) facility and approved by the local Sichuan Provincial CDC ethics committee. Mitogenicity Activity Test to Search for Superantigens To determine the mechanism by which potential superantigens might be produced by S. suis 2, mitogenicity activity was tested in human PBMCs [ 21, 22] ( Protocol S1). Qualitative PCR Assay Routine genomic DNA preparations from all the isolates were done as described [ 23]. Multiplex-PCR (multi-PCR) assays were